2968 Federal Register / Vol. 65, No. 12 / Wednesday, January 19, 2000 / Notices

Type of respondents Number of

respondents

Frequency

of response

Estimated

average response time

Estimated

annual burden hours

Patients/Family ................................................................................................................ 3,600 1.00 0.167 600

Phys. Asst. ....................................................................................................................... 7,200 1.00 0.167 1,200

Physicians ........................................................................................................................ 1,200 1.00 0.167 200

Totals .................................................................................................................... 12,000 .................... .................... 2,000

The annual reporting burden is as

follows: Estimated Number of

Respondents: 12,000; Estimated Number

of Responses over Respondent: 1;

Estimated Average Burden Hours Per

Response: 0.1671; and Estimated Total

Annual Burden Hours Requested: 2,000.

The annualized cost to respondents is

estimated at $39,000. There are no

Capital Costs to report. There are no

Operating or Maintenance Costs to

report.

Request for Comments

Written comments and/or suggestions

from the public and affected agencies

are invited on one or more of the

following points: (1) Whether the

proposed collection of information is

necessary for the proper performance of

the function of the agency, including

whether the information will have

practical utility; (2) the accuracy of the

agency’s estimate of the burden of the

proposed collection of information,

including the validity of the

methodology and assumptions used; (3)

ways to enhance the quality, utility, and

clarity of the information to be

collected; and (4) ways to minimize the

burden of the collection of information

on those who are to response, including

the use of appropriate automated,

electronic, mechanical, or other

technological collection techniques or

other forms of information technology.

Please address all comments

concerning the proposed collection to

Kathy Kranzfelder, Project Officer,

NIDDK Information Clearinghouses,

NIH, Building 31, Room 9A04,

MSC2560, Bethesda, MD 20852. You

may also submit comment and data by

electronic mail (e-mail) at:

kranzfeldk@hq.niddk.nih.gov.

Comments Due Date

Comments regarding this information

are best assured or having their full

effect if received on or before March 20,

2000.

FOR FURTHER INFORMATION CONTACT: To

request more information on the

proposed project, contact Kathy

Kranzfelder at 301–496–3583 or via email at: kranzfeldk@hq.niddk.nih.gov.

L. Earl Laurence,

Deputy Director, NIDDK.

[FR Doc. 00–1153 Filed 1–18–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Fogarty International Center; Notice of

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

Fogarty International Center Advisory

Board.

The meeting will be open to the

public as indicated below, with

attendance limited to space available.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation of other

reasonable accommodations, should

notify the Contact Person listed below

in advance of the meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications

and/or contract proposals and the

discussions could disclose confidential

trade secrets or commercial property

such as patentable material, and

personal information concerning

individuals associated with the grant

applications and/or contract proposals,

the disclosure of which would

constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: Fogarty International

Center Advisory Board.

Date: February 8, 2000.

Open: 8:30 a.m. to 12 p.m.

Agenda: Report of the Director, technology

transfer at NIH, and discussions of Fogarty

International Center organization and

planning.

Place: Lawton Chiles International House,

16 Center Drive (Building 16), Bethesda, MD

20892.

Closed: 12 p.m. to 4 p.m.

Agenda: To review and evaluate grant

applications and/or proposals.

Place: Lawton Chiles International House,

16 Center Drive (Building 16), Bethesda, MD

20892.

Contact Person: Irene W. Edwards,

Information Officer, Fogarty International

Center, National Institutes of Health,

Building 31, Room B2C08, 31 Center Drive

MSC 2220, Bethesda, MD 20892, 301–496–

2075.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.106, Minority International

Research Training Grant in the Biomedical

and Behavioral Sciences; 93.154, Special

International Postdoctoral Research Program

in Acquired Immunodeficiency Syndrome;

93.934, Fogarty International Research

Collaboration Award; 93.989, Senior

International Fellowship Awards Program,

National Institutes of Health, HHS)

Dated: January 11, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–1146 Filed 1–18–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Cancer

Institute Special Emphasis Panel, NonMammalian Organisms as Models for

Anticancer Drug Discovery.

Date: February 2, 2000.

Time: 8 AM to 5 PM.

Federal Register / Vol. 65, No. 12 / Wednesday, January 19, 2000 / Notices 2969

Agenda: To review and evaluate grant

applications.

Place: Executive Plaza North-Conference

Room F, 6130 Executive Blvd., Rockville, MD

20852.

Contact Person: Timothy C. Meeker,

Scientific Review Administrator, Special

Referral and Resources Branch, Division of

Extramural Activities, National Cancer

Institute, 6116 Executive Boulevard, Room

8088, Rockville, MD 20852, 301/594–1279.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support;

93.398, Cancer Research Manpower; 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: January 6, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–1129 Filed 1–18–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Center for Research

Resources; Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Center for

Research Resources Special Emphasis Panel,

General Clinical Research Center.

Date: February 27–28, 2000.

Time: February 27, 2000, 7:00 PM to

Adjournment.

Agenda: To review and evaluate grant

applications.

Place: Double Tree Hotel, 1750 Rockville

Pike, Rockville, MD 20852.

Contact Person: Rebecca A. Fuldner, PhD,

Scientific Review Administrator, Office of

Review, National Center for Research

Resources, 6705 Rockledge Drive, MSC 7965,

Room 6018, Bethesda, MD 20892–7965, (301)

435–0809.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.306, Comparative Medicine,

93.306; 93.333, Clinical Research, 93.333;

93.371, Biomedical Technology; 93.389,

Research Infrastructure, National Institutes of

Health, HHS)

Dated: January 10, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–1132 Filed 1–18–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Center for Research

Resources; Notice of Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given to the following

meetings.

The meetings will be open to the

public as indicated below, with

attendance imited to space available.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

notify the Contact Person listed below

in advance of the meeting.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5,

U.S.C., as amended. The grant

applications and the discussions could

disclose confidential trade secrets or

commercial property such as patentable

material, and personal information

concerning individuals associated with

the grant applications, the disclosure of

which would constitute a clearly

unwarranted invasion of personal

privacy.

Name of Committee: National Center for

Research Resources Initial Review Group,

General Clinical Research Centers Review

Committee.

Date: February 810, 2000.

Open: February 8, 2000, 8:00 AM to 9:30

AM.

Agenda: To discuss program planning and

program accomplishments.

Place: Ramada Inn Rockville, 1775

Rockville Pike, Rockville, MD 20852.

Closed: February 8, 2000, 9:30 AM to

Adjournment.

Agenda: To review and evaluate grant

applications.

Place: Ramada Inn Rockville, 1775

Rockville Pike, Rockville, MD 20852.

Contact Person: Charles G. Hollingsworth,

DRPH, Director, Office of Review, National

Center for Research Resources, 6705

Rockledge Drive, MSC 7965, Room 6018,

Bethesda, MD 208927965, 301–435–0806.

Name of Committee: National Center for

Research Resources Initial Review Group,

Comparative Medicine Review Committee.

Date: February 15–16, 2000.

Open: February 15, 2000, 8:00 AM to 9:30

AM.

Agenda: To discuss program planning and

program accomplishments.

Place: The Bethesda Ramada, Ambassador

One, 8400 Wisconsin Avenue, Bethesda, MD

20814.

Closed: February 15, 2000, 9:30 AM to

Adjournment.

Agenda: To review and evaluate grant

applications.

Place: The Bethesda Ramada, Ambassador

One, 8400 Wisconsin Avenue, Bethesda, MD

20814.

Contact Person: John D. Harding, Phd,

Scientific Review Administrator, Office of

Review, National Center for Research

Resources, 6705 Rockledge Drive, MSC 7965,

Room 6018, Bethesda, MD 208927965, (301)

435–0810.QP=‘oz’

Name of Committee: Scientific and

Technical Review Board on Biomedical and

Behavioral Research Facilities.

Date: February 16, 2000.

Open: 8:00 AM to 9:00 AM.

Agenda: To discuss program planning and

program accomplishments.

Place: Hyatt Regency Hotel, One Bethesda

Metro Center, Bethesda, MD 20814.

Closed: 9:00 AM to Adjournment.

Agenda: To review and evaluate grant

applications.

Place: Hyatt Regency Hotel, One Bethesda

Metro Center, Bethesda, MD 20814.

Contact Person: D.G. Patel, PhD, Scientific

Review Administrator, Office of Review,

National Center for Research Resources, 6705

Rockledge Drive, MSC 7965, Room 6018,

301–435–0824.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.306, Comparative Medicine,

93.306; 93.333, Clinical Research, 93.333;

93.371, Biomedical Technology; 93.389,

Research Infrastructure, National Institutes of

Health, HHS)

Dated: January 10, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 001133 Filed 11800; 8:45 am]

BILLING CODE 414001M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Center for Research

Resources; Notice of Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The messages will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,